PVN presympathetic neurons, projecting to the rostral ventrolateral medulla (RVLM) or the spinal cord, play a critical role in the regulation of blood pressure. BDNF is a neurotrophic factor known to be upregulated in the PVN in response to hypertensive stimuli such as stress. However, the mechanisms by which BDNF modulates cardiovascular regulation in the PVN remains unclear. BDNF alters glutamatergic and GABAergic signaling, as well as neuronal morphology broadly in the central nervous system. Within the PVN, glutamatergic synaptic input and NMDA‐signaling are elevated, while GABAergic inhibition is reduced in hypertensive models. We tested the hypothesis that increased BDNF expression in the PVN elevates blood pressure by enhancing NMDA‐signaling, diminishing GABAA‐signaling and altering morphology of RVLM‐projecting PVN neurons. To simulate stress‐related upregulation of BDNF in the PVN, an AAV2 viral vector expressing BDNF was bilaterally injected into the PVN of Sprague Dawley rats, while control rats received AAV2‐GFP injections. Three weeks later, blood pressure and heart rate responses to PVN injections of NMDA and GABAA agonists and antagonists were recorded under anesthesia. Our results showed that inhibition of NMDA receptors with AP5 induced significantly larger decreases in blood pressure and heart rate in the BDNF group (−23±4 mmHg and −56±17 BPM) compared with the GFP group [5±1 mmHg (p<0.01) and −5±1 BPM (p<0.05)]. In contrast, activation of NMDA receptors with NMDA induced similar cardiovascular responses in GFP and BDNF animals. Inhibition of GABAA receptors with gabazine induced significantly smaller blood pressure increases in the BDNF group (32±6 mmHg) compared to GFP (61±11 mmHg, p<0.05), but heart rate responses were similar in the two groups. Activation of GABAA receptors with muscimol caused significantly reduced hypotensive responses in the BDNF group (−14±2 mmHg) compared to GFP (−23±4 mmHg, p<0.05), while changes in heart rate were similar. Quantitative RT‐PCR from PVN brain punches indicated that expression of NMDAR1 or GABAA‐Δ was unaffected by BDNF overexpression. However, immunofluorescence imaging in PVN brain sections demonstrated that BDNF significantly increased the soma size of RVLM‐projecting PVN neurons. In summary, our findings indicate that BDNF augments glutamate signaling in the PVN, primarily by increasing presynaptic glutamate release, and reduces GABA inhibition possibly through postsynaptic mechanisms. Finally, BDNF may also affect the balance of excitatory/inhibitory synaptic balance and regulation of blood pressure by increasing the soma size of PVN‐RVLM neurons.Support or Funding InformationR01 HL133211‐01A1.